EVNIN LUKE
Transactions
50
Companies
47
Filings
6
CIK
0001134657
Recent Transactions
- Sale
- Sale
- Sale
- Sale
- Conversion
- ConversionAktis Oncology, Inc.$AKTS
Series Seed Redeemable Convertible Preferred Stock
2026-01-12−5,000,000→ 0 total - ConversionAktis Oncology, Inc.$AKTS
Series B Redeemable Convertible Preferred Stock
2026-01-12−6,000,000→ 0 total - Conversion
- Conversion
- ConversionAktis Oncology, Inc.$AKTS
Series A Redeemable Convertible Preferred Stock
2026-01-12−22,500,000→ 0 total - Sale
- Purchase
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
- Sale
Companies
47Acorda Therapeutics, Inc.
10% Owner
- $AKTS
Aktis Oncology, Inc.
10% Owner
- $ALT
Altimmune, Inc.
10% Owner
ALUS Liquidation Corp
10% Owner
ARATANA THERAPEUTICS, INC.
10% Owner
ARYx Therapeutics, Inc.
10% Owner
- $AVTX
Avalo Therapeutics, Inc.
10% Owner
AVEO PHARMACEUTICALS, INC.
10% Owner
BARRIER THERAPEUTICS INC
10% Owner
CHIASMA, INC
10% Owner
CORNERSTONE THERAPEUTICS INC
10% Owner
COTHERIX INC
10% Owner
CRYOCOR INC
10% Owner
- $DYN
Dyne Therapeutics, Inc.
10% Owner
- $TRDA
Entrada Therapeutics, Inc.
10% Owner
EPIRUS Biopharmaceuticals, Inc.
10% Owner
Epizyme, Inc.
10% Owner
Harpoon Therapeutics, Inc.
Director, 10% Owner
HELICOS BIOSCIENCES CORP
10% Owner
HEMOSENSE INC
10% Owner
Histogen Inc.
10% Owner
HUMANIGEN, INC
10% Owner
IPASS INC
10% Owner
iTeos Therapeutics, Inc.
Former 10% Owner
MEMORY PHARMACEUTICALS CORP
10% Owner
METABASIS THERAPEUTICS INC
Director, 10% Owner
Oncorus, Inc.
Director, 10% Owner
OSCIENT PHARMACEUTICALS CORP
10% Owner
- $PCRX
Pacira BioSciences, Inc.
Director, 10% Owner
PEPLIN INC
10% Owner
Pernix Sleep, Inc.
10% Owner
Pharmasset Inc
Former 10% Owner
PONIARD PHARMACEUTICALS, INC.
10% Owner
Radius Health, Inc.
10% Owner
- $RPTX
Repare Therapeutics Inc.
10% Owner
ReShape Weightloss Inc.
Director, 10% Owner
- $RYTM
RHYTHM PHARMACEUTICALS, INC.
10% Owner
- $RIGL
RIGEL PHARMACEUTICALS INC
10% Owner
SENORX INC
10% Owner
- $SNDX
Syndax Pharmaceuticals Inc
Director, 10% Owner
TCR2 THERAPEUTICS INC.
10% Owner
TERCICA INC
10% Owner
- $TMUS
T-Mobile US, Inc.
10% Owner
TURMERIC ACQUISITION CORP.
Chief Executive Officer
- $VSTM
Verastem, Inc.
Former 10% stockholder
VIACELL INC
10% Owner
- $HOWL
Werewolf Therapeutics, Inc.
Director
Recent Filings
6Address
C/O MPM BIOIMPACT LLC 399 BOYLSTON STREET, SUITE 1100
BOSTON, MA, 02116